Q2 2023

Filed Aug 21, 2023 · 10-Q · 52 days after period end · 0001096906-23-001655

Q2 2023 · 10-Q

Revenue

$9.93K

— vs Q2 2022

Net Income

-$3.72M

N/M vs Q2 2022

EPS Diluted

-$0.02

N/M vs Q2 2022

Gross Profit$9,929—

Operating Income

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$9.93K	$0.00	$14.88K	$0.00
Net Income	-$3.72M	-$1.22M	-$3.83M	-$79.39K
EPS Diluted	-$0.02	-$0.01	-$0.03	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR